WAKAYAMA MEDICAL UNIVERSITY

Gut Microbiome Metabolite HYA Shows Promise for Blood Sugar Management in Type 1 Diabetes

- A novel study reveals that HYA, a gut microbiome-derived metabolite, effectively reduces post-meal blood sugar spikes in type 1 diabetes model rats through multiple mechanisms. - Researchers from Wakayama Medical University, Hokkaido University, and Noster Inc. demonstrated that HYA enhances gut hormone secretion and inhibits glucose absorption without triggering inflammatory responses. - When combined with standard insulin therapy, HYA provided additional improvements in postprandial glucose control, suggesting potential as a complementary approach to traditional diabetes management.